2-HF Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitors by Inhibiting STAT3 Pathway

被引：0
|
作者：
Dong, S. B. [1 ]
Yue, Y. Y. [1 ]
Ma, Q. Y. [1 ]
Wu, Z. [1 ]
Wang, Z. [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Peoples R China
来源：
PANCREAS | 2019年 / 48卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1420 / 1420
页数：1
相关论文
共 50 条
  • [1] Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
    Lehe Yang
    Shichong Lin
    Yanting Kang
    Youqun Xiang
    Lingyuan Xu
    Jifa Li
    Xuanxuan Dai
    Guang Liang
    Xiaoying Huang
    Chengguang Zhao
    Journal of Experimental & Clinical Cancer Research, 38
  • [2] Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
    Yang, Lehe
    Lin, Shichong
    Kang, Yanting
    Xiang, Youqun
    Xu, Lingyuan
    Li, Jifa
    Dai, Xuanxuan
    Liang, Guang
    Huang, Xiaoying
    Zhao, Chengguang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [3] Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
    Zhuang, Yan
    Bai, Ying
    Hu, Yan
    Guo, Yueqin
    Xu, Lingyuan
    Hu, Wanle
    Yang, Lehe
    Zhao, Chengguang
    Li, Xiaokun
    Zhao, Haiyang
    ONCOTARGETS AND THERAPY, 2019, 12 : 5281 - 5291
  • [4] Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling
    Zheng, Hailun
    Yang, Lehe
    Kang, Yanting
    Chen, Min
    Lin, Shichong
    Xiang, Youqun
    Li, Caleb
    Dai, Xuanxuan
    Huang, Xiaoying
    Liang, Guang
    Zhao, Chengguang
    MOLECULAR CARCINOGENESIS, 2019, 58 (04) : 565 - 576
  • [5] Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway
    Wang, Zhaohong
    Chen, Hui
    Chen, Jingjing
    Hong, Zhong
    Liao, Yi
    Zhang, Qiyu
    Tong, Hongfei
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8463 - 8473
  • [6] 2′-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling
    Yue, Yangyang
    Qian, Weikun
    Li, Jie
    Wu, Shiqi
    Zhang, Mengzhao
    Wu, Zheng
    Ma, Qingyong
    Wang, Zheng
    CANCER LETTERS, 2020, 471 : 135 - 146
  • [7] 2′-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling (vol 471, pg 135, 2020)
    Yue, Yangyang
    Qian, Weikun
    Li, Jie
    Wu, Shiqi
    Zhang, Mengzhao
    Wu, Zheng
    Ma, Qingyong
    Wang, Zheng
    CANCER LETTERS, 2024, 583
  • [8] 2′-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling (vol 471, pg 135, 2020)
    Yue, Yangyang
    Qian, Weikun
    Li, Jie
    Wu, Shiqi
    Zhang, Mengzhao
    Wu, Zheng
    Ma, Qingyong
    Wang, Zheng
    CANCER LETTERS, 2022, 549
  • [9] EGCG enhances the therapeutic potential of gemcitabine and CP690550 (Tasocitinib) by inhibiting STAT3 signaling pathway in human pancreatic cancer cells
    Tang, Su-Ni
    Fu, Junsheng
    Shankar, Sharmila
    Srivastava, Rakesh K.
    CANCER RESEARCH, 2012, 72
  • [10] Quinolone-indolone conjugate induces apoptosis by inhibiting the EGFR-STAT3-HK2 pathway in human cancer cells
    Liu, Ying-Hua
    Wei, Xiao-Li
    Hu, Guo-Qiang
    Wang, Tian-Xiao
    MOLECULAR MEDICINE REPORTS, 2015, 12 (02) : 2749 - 2756
12345